华西医学

华西医学

2018 年美国心脏协会心肺复苏与心血管急救指南更新解读—儿童高级生命支持

查看全文

2018 年 11 月美国心脏协会更新了心肺复苏与心血管急救指南。此次更新再次践行了“指南只要有新证据将及时更新”的原则,对儿童电击除颤难以纠正的心室颤动/无脉性室性心动过速的抗心律失常药物治疗进行了证据回顾并提出治疗建议,并非对 2015 版指南进行全面修订。更新由国际复苏联络委员会儿科工作组完成,重申了 2015 年儿童高级生命支持指南推荐,以及儿童电击除颤难以纠正的心室颤动/无脉性室性心动过速可使用抗心律失常药物利多卡因或胺碘酮治疗。

In November 2018, the American Heart Association (AHA) updated Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Rather than a comprehensive revision of the 2015 edition guidelines, the 2018 AHA guidelines update was updated again according to the rule " the update of the guideline is whenever new evidence is available”, providing the evidence review and treatment recommendation for antiarrhythmic drug therapy in pediatric shock-refractory ventricular fibrillation/pulseless ventricular tachycardia cardiac arrest. The Pediatric Task Force of the International Liaison Committee on Resuscitation updated the guideline, reaffirming the 2015 pediatric advanced life support guideline recommendation that either lidocaine or amiodarone may be used to treat pediatric patients with shock-refractory ventricular fibrillation or pulseless ventricular tachycardia.

关键词: 美国心脏协会; 高级生命支持; 指南; 儿童; 抗心律失常药物治疗

Key words: American Heart Association; Advanced life support; Guidelines; Children; Antiarrhythmic drug therapy

引用本文: 周艳, 李熙鸿. 2018 年美国心脏协会心肺复苏与心血管急救指南更新解读—儿童高级生命支持. 华西医学, 2018, 33(11): 1356-1358. doi: 10.7507/1002-0179.201811066 复制

登录后 ,请手动点击刷新查看全文内容。 没有账号,
1. Jonathan P, Alexis T, Marc B, et al. 2018 American Heart Association focused update on pediatric advanced life support. Circulation, 2018. doi: 10.1161/CIR.0000000000000612.
2. Halperin JL, Levine GN, Al-Khatib SM, et al. Further evolution of the ACC/AHA clinical practice guideline recommendation classification system: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. Circulation, 2016, 133(14): 1426-1428.
3. Kudenchuk PJ, Cobb LA, Copass MK, et al. Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation. N Engl J Med, 1999, 341(12): 871-878.
4. Dorian P, Cass D, Schwartz B, et al. Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation. N Engl J Med, 2002, 346(12): 884-890.
5. Valdes SO, Donoghue AJ, Hoyme DB, et al. Outcomes associated with amiodarone and lidocaine in the treatment of in-hospital pediatric cardiac arrest with pulseless ventricular tachycardia or ventricular fibrillation. Resuscitation, 2014, 85(3): 381-386.